Why BPC-157 Purity Matters: Understanding Janoshik COA Testing

Research Disclaimer: BPC-157 is sold exclusively for in-vitro and laboratory research use. Certificate of analysis data described in this article is specific to individual product batches. This content does not constitute medical advice.

Purity is the most important quality parameter for any research peptide — and it is also the parameter most frequently misrepresented, misunderstood, or simply omitted by suppliers. A product labeled "BPC-157" tells you nothing about what percentage of the vial actually contains the target sequence, or what the remaining percentage consists of.

A certificate of analysis (COA) from an independent laboratory changes that. But only if you know how to read one.

This article explains what Janoshik testing means, how to interpret HPLC purity data for BPC-157, and what to look for in a COA before trusting a batch for research.

Table of Contents#

1. Why Purity Matters in Peptide Research
2. What Is a Certificate of Analysis?
3. Who Is Janoshik and Why They Are the Standard
4. How HPLC Measures Peptide Purity
5. Reading a BPC-157 COA: Line by Line
6. What Is in the Impurity Fraction?
7. Mass Spectrometry Confirmation
8. Purity Thresholds: What Research Requires
9. Red Flags in Supplier Claims
10. Frequently Asked Questions
11. Key References

Why Purity Matters in Peptide Research#

The practical importance of purity shows up at the dose level. BPC-157 is typically used at 10 µg/kg in rat models. For a 300g rat, that is 3 µg per animal. At this scale:

A 15% dose error is not negligible in mechanistic research. It is the difference between a sub-threshold and a therapeutically relevant dose in a dose-response study. If you are comparing two treatment groups or replicating a published protocol, a systematic dose error makes your results incomparable to the literature.

Beyond quantity, the 5–15% impurity fraction itself may have biological activity. Truncated sequence fragments, oxidized side chains, and synthesis byproducts can act as antagonists, partial agonists, or off-target ligands at receptors you are not studying.

What Is a Certificate of Analysis?#

A certificate of analysis is a document issued by a testing laboratory that reports the results of analytical tests performed on a specific batch of material. For research peptides, a COA typically reports:

• Purity (% active compound by HPLC area)
• Identity confirmation (mass spectrometry — measured vs. theoretical molecular weight)
• Appearance (visual inspection: color, form)
• Solubility (dissolves in water/buffer — confirmatory)
• Batch/lot number (links the COA to a specific production run)
• Test date (so you know how old the analysis is)

A COA without a batch number and test date is essentially untraceable. A COA with a batch number allows you to verify that the product you receive matches the tested material.

Who Is Janoshik and Why They Are the Standard#

Janoshik is an independent analytical chemistry laboratory that specializes in testing research chemicals, peptides, and pharmaceutical compounds. Their reputation in the research peptide community is based on:

1. Independence: Janoshik is not affiliated with any supplier. Their tests cannot be commissioned by a supplier to produce a predetermined result — the lab's business model depends on honest reporting.

2. Established methodology: They use reverse-phase HPLC (RP-HPLC) as the primary purity method — the same analytical method used in pharmaceutical quality control.

3. Traceability: Each COA includes a unique report number that can be cross-referenced through Janoshik's website. A legitimate Janoshik COA can be verified online; a fabricated one cannot.

4. Published results: Janoshik posts test results publicly on their website, which allows researchers and consumers to independently search results without relying on the supplier.

The key point: a supplier can fabricate a COA document. A supplier cannot fabricate a Janoshik report number that resolves to the claimed result on the Janoshik website. This is why Janoshik verification specifically is more meaningful than a generic "COA included."

How HPLC Measures Peptide Purity#

Reverse-phase high-performance liquid chromatography (RP-HPLC) separates peptides by hydrophobicity. The sample is injected into a column packed with C18 particles (octadecyl chains bound to silica). Peptides with different structures (different amino acid sequences, oxidized residues, truncated fragments) interact differently with the stationary phase and elute at different times.

A UV detector at 214–220 nm measures absorbance as each component exits the column. The output is a chromatogram — a graph of absorbance vs. retention time with peaks for each detectable component.

Purity calculation#

HPLC purity is reported as % area — the area of the main peak (BPC-157) as a percentage of the total area of all detected peaks.

If the BPC-157 peak area = 99,100 and the total area of all peaks = 100,000, purity = 99.1%.

This calculation is purely quantitative — it measures what fraction of UV-absorbing material at 214 nm elutes at the expected retention time. It does not distinguish between different types of impurities in the remaining 0.9%, only that they are present and measurable.

Reading a BPC-157 COA: Line by Line#

A typical Janoshik COA for BPC-157 includes these sections:

Header#

• Compound name: BPC-157 (or full IUPAC name or sequence)
• CAS number: 137525-51-0 (for synthetic BPC-157)
• Batch/lot number: Unique identifier linking to the product lot
• Report number: Cross-referenceable on janoshik.com
• Test date: Date the analysis was performed

Test results table#

HPLC chromatogram#

The COA should include or link to the actual chromatogram image showing the main BPC-157 peak and the baseline. The main peak should be symmetric and dominant. Multiple significant peaks in the chromatogram are a red flag — they indicate high impurity content regardless of the calculated % area.

Mass spectrometry (identity confirmation)#

BPC-157 has a theoretical molecular weight of 1419.55 Da (average) for the free base peptide. The MS measurement should match this within acceptable instrument error (typically ±0.5 Da for ESI-MS at this mass range). A match confirms the correct sequence was synthesized.

What Is in the Impurity Fraction?#

For a batch reporting 99.1% purity, the 0.9% impurity fraction typically consists of:

Synthesis byproducts:

• Truncated sequences: peptides where one or more amino acids were not coupled during solid-phase synthesis. In a 15-amino-acid peptide like BPC-157, truncated sequences at any of the 14 coupling steps are possible. Modern synthesis chemistry minimizes these to below 1%.
• Deletion sequences: peptides missing one specific internal residue due to an incomplete coupling cycle
• Oxidized methionine: the methionine residue in BPC-157 can be oxidized to methionine sulfoxide during synthesis or purification. Methionine sulfoxide is a distinct peptide with potentially different (or no) bioactivity.
• Aggregated species: higher-molecular-weight aggregates formed during purification
• Residual solvents: trace acetonitrile or TFA from the HPLC purification step — at 0.1–0.5%, these have no documented biological effect at research doses

Why this matters:

Oxidized methionine and truncated sequences are the impurities most likely to have biological effects. If oxidized BPC-157 acts as a partial agonist at the BPC-157 target, even a 1–2% contamination systematically shifts your dose-response curve. For mechanistic studies, this is worth considering.

Mass Spectrometry Confirmation#

HPLC purity tells you that the main peak is 99.1% of the UV-absorbing material. It does not confirm what that main peak is. Mass spectrometry (MS) provides identity confirmation by measuring molecular weight.

BPC-157 theoretical mass#

The sequence of BPC-157 is: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

• Theoretical MW (monoisotopic): 1418.72 Da
• Theoretical MW (average): 1419.55 Da

A COA with ESI-MS data should report the measured m/z value and the corresponding calculated MW. For multi-charge-state ESI, you may see [M+H]⁺ or [M+2H]²⁺ ions — the COA should resolve these to the parent neutral mass for comparison to the theoretical value.

Match = identity confirmed. Mismatch = wrong compound or heavily modified peptide.

Purity Thresholds: What Research Requires#

For any study that will be reported or compared to published data, 99%+ purity with MS identity confirmation is the appropriate standard. Most of the Sikiric group publications do not specify the purity of the BPC-157 used, but they sourced compounds from established peptide synthesis companies — in all likelihood at 98–99%+ purity.

Red Flags in Supplier Claims#

When evaluating a peptide supplier's purity claims, watch for:

"We test every batch" without specifying the method or lab — self-testing by the supplier is not independent.

COA without a verifiable report number — cannot be authenticated.

COA listing only "appearance" and "solubility" without HPLC purity or MS — these tests confirm nothing about chemical identity or purity.

Purity claims of "99%+" without supporting data — the claim is meaningless without the chromatogram and the method.

Old COAs — test dates from years ago do not apply to current batches. Each production lot should have its own analysis.

Shared COAs — a single COA applied to multiple products or batches. Every batch is different; a COA for one batch does not represent another.

Frequently Asked Questions#

What does "99.1% purity by HPLC" actually mean? It means 99.1% of the UV-absorbing material eluting from the HPLC column at the expected retention time is BPC-157. The remaining 0.9% are other UV-absorbing species — synthesis impurities, oxidized residues, or truncated fragments.

Is 99.1% better than 99%? Marginally. Both are research-grade. The distinction matters at the dose level: for a 3 µg dose, the difference between 99.0% and 99.1% purity is 0.003 µg — below measurement noise. The significant threshold is between 95% and 99%+.

How do I verify a Janoshik COA? Go to janoshik.com and use the search function to look up the report number on the COA. If the number resolves to a matching report, the COA is authentic.

Does purity decline over time? Yes. Peptide purity decreases with storage time, especially in reconstituted form. A COA reflects purity at the time of testing. Proper storage (see our stability article) minimizes subsequent degradation.

Should I test the batch I receive? For critical experiments, yes. You can submit a sample to Janoshik or another independent lab for independent confirmation. This adds cost but eliminates doubt about batch-to-batch consistency.

Key References#

1. USP (2021). "Peptide Purity by HPLC." United States Pharmacopeia, General Chapter <621>.

2. Meienhofer J, et al. (1979). "Solid phase synthesis of crystalline glucagon." International Journal of Peptide and Protein Research, 13(1):35–42.

3. Sikiric P, et al. (2016). "Novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157." Current Pharmaceutical Design, 22(8):1011–1040.

4. ICH Q6A (1999). "Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances." International Council for Harmonisation.

5. Manning MC, et al. (2010). "Stability of protein pharmaceuticals: an update." Pharmaceutical Research, 27(4):544–575.

Research Use Only: BPC-157 and all products referenced are sold exclusively for in-vitro research and laboratory use. Not for human consumption. JuicedPharma does not provide medical advice.

Published by JuicedPharma Research Team · September 2026 · Category: Research Protocols & Science